___
Chat GPT summarizes;
The Washington Post article is worth reading because it shows how quickly AI medicine is moving from speculative futurism into federal and state policy. The main story is not just that chatbots may help patients, but that some officials and entrepreneurs are now openly contemplating AI systems that diagnose, triage, refill prescriptions, and eventually practice medicine with limited human oversight.
The article centers on Amy Gleason, now advising HHS on AI, and describes a broader Trump administration push to integrate AI into health care through
- prescription-refill pilots,
- cardiovascular triage research,
- FDA digital-health fast tracks,
- Medicaid reimbursement for AI wellness tools, and
- possible future regulation of “independent AI doctors.”
For readers interested in FDA policy, digital health, medical liability, access to care, or reimbursement, this is an early map of a major coming policy battlefield.
###
Chat GPT also researched Amy Gleason's background, as follows:
Amy Gleason began in nursing, including emergency-room nursing, then moved into health-care technology, especially electronic medical records, practice-management systems, interoperability, and patient access to data. An archived White House profile from the Obama-era Precision Medicine Initiative says she “began her career in nursing” and then spent years building and implementing EMR and practice-management technologies.
Her personal story is central to her public identity. Her daughter Morgan developed a rare autoimmune disease, often described as juvenile dermatomyositis / juvenile myositis, and Gleason became intensely focused on the failures of fragmented medical records and data access. The WaPo article says Morgan later uploaded years of medical records into ChatGPT, leading to a different diagnostic framing and trial eligibility.
Professionally, she co-founded or helped lead CareSync, a health-care coordination / records company, and later worked in digital-health roles including Russell Street Ventures, Main Street Health, and CareBridge.
In government, she worked with the U.S. Digital Service [bringing tech experts and government together, under Obama), including health-data modernization projects. She is now described as Acting Administrator of the U.S. DOGE Service, and Strategic Advisor to CMS, focused on modernization, interoperability, and AI/data systems in health care.
So, in one sentence: Amy Gleason is a former nurse turned health-tech executive and patient-data advocate whose personal experience with her daughter’s rare disease pushed her toward interoperability, federal digital services, and now AI-driven health-system modernization.
